Search for company

Kahira Pharmaceuticals & Chemical Industries Co. S.A.E (القاهرة للأدوية والصناعات الكيماوية) (Egypt)

Quote Chart
Quote Summary
Last Price 16.00
Volume 700
Turnover 11,200
Index الرعاية الصحية والأدوية
Market البورصة المصرية
Ticker CPCI.CA
Market Cap Market Cap 191,152
52 Week High 22.45
52 Week Low 14.35
P/E 4.41
EPS 3.63
Dividend Yield 1.26 (تشرين الثاني 05, 2015)
Bookvalue 551,878
Enterprise Value 144,935
Quote updated on February 11, 2016
Note: data in EGP Thousands.
Select Items to chart them. 2016 Q1
Net sales revenue
Total Operating Revenue
Operating profit (EBIT)
Net Profit(Loss)
Total Assets 509,893
Total equity
Operating Profit Margin
Return on Sales (ROS)
Return on Equity (ROE)
Debt to equity
Quick ratio
Cash Ratio
Note: units in Thousands. Statement: Audited, Consolidated
Source: World's Vest Base, EMIS Company Database.
Company Description

Kahira Pharmaceuticals was established in 1962 through the merger of leading laboratories. Kahira Pharmaceuticals is headquartered in Cairo and it is engaged in production and distribution of human and veterinary pharmaceuticals products, such as analgesics, antipyretics, antirheumatics, vitamins, antibiotics, eye and nasal drops. The company is engaged in the production of cosmetics and other chemical products as well. Kahira Pharmaceuticals exports its production to the Gulf countries, Africa, Kazakhstan,…

Main Products

Human and veterinary drugs, cosmetics, chemical products

Contact Information

Legal Address
4 Abd El-Hamed El-Deeb St.,Victoria Sguare, Shoubra,P.O Box 793
Cairo; Greater Cairo; Map
Tel: +20-22028596,+20-22021431
Fax: +20-22025477

Full name: Kahira Pharmaceuticals & Chemical Industries Co. S.A.E

Status: Listed
Legal Form: Joint Stock Company
Operational Status: Operational
ISIN Code: EGS38391C016
Incorporation Date: 1991

Basic Information
Total Employees:
Outstanding Shares:
: ()
Registered Capital:
Financial Auditors:
Key Executives
Ownership Details
Pharmaceuticals Holding Company
Corporate Actions
EMIS Benchmark Score
EMIS DealWatch Deals
DealMonitor Deal Intents
EMIS DealWatch News
Financial Documents/Annual Reports
Competitors - Egypt

Register Your Interest

Receive our Global EMIS Insider

The Global EMIS Insider is a our monthly source of Emerging Markets Information Service (EMIS) functionality enhancements and new content releases in each of our countries worldwide.
First Name: *
Country: *
Last Name: * Company: *
Email: * Position: *
Security Code: *   * Indicates required field.

EMIS is part of the Euromoney Institutional Investor PLC group of companies. Click here for more details on our group's activities.
We will use the information you provide here to process your order/registration/request including communicating with you about it. If you are registering for a trial, you will receive a follow up email and/or call asking you about your trial. As part of the trial, you may also receive email updates and other features as specified for that product. We may monitor your use of our website(s). As an international group, we may transfer your data on a global basis. Subject to your choices below, we may also use your data for marketing purposes. By submitting your details, you will be indicating your consent to the use of your data as identified here. Further information is set out in our privacy policy on this site.

Please tick if you don't want to receive details of products, services and special offers from our group companies by:

Phone    Fax    Email    Mail

Please tick if you don't want to receive details of relevant products, services and special offers from selected companies outside our group

I have read and agree to the Terms and Conditions.

I have read and agree to the Privacy Policy.